← Leaderboards
Riya Muckom
Axent Biosciences Inc.
$685,839
Attributed
$685,839
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $422.2K · FY2021–22$500K$375K$250K$125K$0
'21
'22
Funding mix
By agency
NIH$685,839 · 1
By mechanism
R43$685,839 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Adult”
- Beth Baseler · Leidos Biomedical Research, Inc.$127,607,354
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$93,592,175
- Susan M Landau · University Of California Berkeley$47,252,026
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Evan Z Macosko · Broad Institute, Inc.$32,116,761
Research focus
AdultAffectAnimal Disease ModelsAnimalsAntibodiesAreaBaseBenchmarkingBiological SciencesBioreactorsBrainCell CountCell Culture TechniquesCell DimensionCell Replacement TherapyCellsCell SurvivalCell TherapyCell TypeChemistryClinicClinical DevelopmentCombinatorial3-Dimensional
Grant awards (2)
A Thermoreversible 3D Manufacturing Platform for Scalable Production of Dopaminergic Neurons for Parkinson's Disease Therapy$263,672
R43 · FY2022 · NS · contact PI
A Thermoreversible 3D Manufacturing Platform for Scalable Production of Dopaminergic Neurons for Parkinson's Disease Therapy$422,167
R43 · FY2021 · NS · contact PI